Karyopharm Therapeutics Inc.
KPTIQ· OTC
Released May 4, 2017, after the close
10-Q filed May 4, 2017, 34 days after period end · 0001193125-17-158670
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $68.00K | — | — | $171.00K |
| Net Income | -$29.92M | -$27.06M | -$26.07M | -$13.69M |
| EPS Diluted | -$0.71 |
Karyopharm Therapeutics Inc. · CIK 1503802 · Engraved from SEC EDGAR
| -$0.75 |
| -$0.74 |
| -$0.46 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.